Gracell Biotechnologies to Participate in Citi 2022 Virtual Immuno-Oncology Summit

Go back to Gracell Biotechnologies to Participate in Citi 2022 Virtual Immuno-Oncology Summit
(NASDAQ: GRCL) Delayed: 10.25 --0 (-0%)
Previous Close $10.25    52 Week High $ 
Open $0.76    52 Week Low $ 
Day High $10.25    P/E N/A 
Day Low $10.25    EPS $ 
Volume 17,211